Oncology and multispecialty revenue jumped 33% to $14.22 billion, the engine behind a fourth straight quarterly beat and a raised full-year adjusted EPS outlook of $44.20 to $45.00. Next catalyst: the planned spinoff of the medical-surgical unit as Wellverse, with Apollo already paying $1.25 billion for a 13% stake.
McKesson :
MCK
MCK
Stock Data
$869.58
$1.80 (0.21%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DISTRIBUTION
Mckesson Corporation is a global healthcare services provider, offering a wide range of products and services. Its operations span across pharmaceutical distribution, including branded, generic, and specialty drugs, as well as over-the-counter products. The company also delivers technology solutions for pharmacies, practice management, and clinical support to specialty practices. Additionally, Mckesson plays a crucial role in connecting various healthcare stakeholders, such as patients, pharmacies, and biopharma companies, through its Prescription Technology Solutions. It further supports healthcare providers with medical-surgical supplies and logistics. Founded in 1833, Mckesson is headquartered in Irving, Texas, serving customers in the U.S. and internationally.
Latest Activity
All McKesson Articles
71 Articles